Telomir Pharmaceuticals Insider Trades
NASDAQ: TELOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Telomir Pharmaceuticals insider activity
Over the last 12 months, Telomir Pharmaceuticals insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Aminov Erez (CEO and Chairman) reporting a transaction in 7,319,710 shares at $1.37 on Apr 22, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TELO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TELO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 22, 2026 | Aminov ErezCEO and Chairman | other | 7,319,710 | $10.03M | Form 4 |
| Feb 13, 2024 | Bay Shore Trust & McNulty Brian Patrick10% Owner | Buy | 49,000 | $343.00K | Form 4 |
| Feb 13, 2024 | Bay Shore Trust & McNulty Brian Patrick10% Owner | Buy | 40,000 | $280.00K | Form 4 |
| Feb 13, 2024 | Bay Shore Trust & McNulty Brian Patrick10% Owner | Buy | 49,000 | $343.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4